Montai is harnessing nature's power through digital technology to treat and prevent chronic disease, hence improving health outcomes for as many people as possible. To address this crucial global concern, the business is pioneering cutting-edge technology to develop AnthromoleculeTM medications, which are derived from a privileged class ofcompounds with a history of safe human use. Our human-centered foundation can enable the rapid and repeatable development of safe, efficacious, and accessible medicines for as many diseases and people as possible by creating the world's first Anthromolecule Bioactivity Atlas, which comprehensively maps potent connections to all known biological pathways underlying disease.

Health Care

Montai Health

Ignacio Martinez

Lamya Shihabuddin

Jayant Bhambhani

Dan Adams

Kyle Chiang

Samadrita Bhattacharyya, PhD

Noubar Afeyan

Caitlin OBrien

The Scientific Research and Development team at Montai Health is responsible for the discovery and development of AnthromoleculeTM medications. This multidisciplinary team leverages digital technology, advanced analytics, and machine learning to map the bioactivity of natural compounds, enabling rapid identification of potential therapeutic agents. By integrating computational modeling, preclinical biology, and translational research, the team aims to create safe, effective, and accessible treatments for a wide range of chronic diseases.

Scientific Research and Development

Leadership Team

Engineering and Product Team

Scientific Research and Development

About

Team members

Other teams at Montai Health

Leadership Team

Engineering and Product Team